Cargando…
Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels
The dioxonapthoimidazolium YM155 is a survivin suppressant which has been investigated as an anticancer agent in clinical trials. Here, we investigated its growth inhibitory properties on a panel of immortalized and patient derived renal cell carcinoma (RCC) cell lines which were either deficient in...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459331/ https://www.ncbi.nlm.nih.gov/pubmed/28582447 http://dx.doi.org/10.1371/journal.pone.0178168 |